BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7650678)

  • 1. Unusual single-stranded polyribonucleotides as potent anti-HIV agents.
    Broom AD; Agrawal VK; Tutonda MG; Fain HD; Buckheit RW
    J Med Chem; 1995 Aug; 38(17):3253-7. PubMed ID: 7650678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).
    Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Senseless" antiviral polyribonucleotides: poly (1-propargylinosinic acid).
    Hyde RM; Buckheit RW; Broom AD
    Nucleosides Nucleotides Nucleic Acids; 2002; 21(1):45-54. PubMed ID: 11995639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones.
    Artico M; Silvestri R; Massa S; Loi AG; Corrias S; Piras G; La Colla P
    J Med Chem; 1996 Jan; 39(2):522-30. PubMed ID: 8558522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors.
    Buckheit RW; Fliakas-Boltz V; Decker WD; Roberson JL; Pyle CA; White EL; Bowdon BJ; McMahon JB; Boyd MR; Bader JP
    Antiviral Res; 1994 Sep; 25(1):43-56. PubMed ID: 7529014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2.
    Manfredi KP; Blunt JW; Cardellina JH; McMahon JB; Pannell LL; Cragg GM; Boyd MR
    J Med Chem; 1991 Dec; 34(12):3402-5. PubMed ID: 1766007
    [No Abstract]   [Full Text] [Related]  

  • 7. PMTI, a broadly active unusual single-stranded polyribonucleotide, inhibits human immunodeficiency virus replication by multiple mechanisms.
    Buckheit RW; Lackman-Smith C; Snow MJ; Halliday SM; White EL; Ross LJ; Agrawal VK; Broom AD
    Antivir Chem Chemother; 1999 Jan; 10(1):23-32. PubMed ID: 10079876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
    Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR
    J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents.
    Buckheit RW; Germany-Decker J; Hollingshead MG; Allen LB; Shannon WM; Janssen PA; Chirigos MA
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1097-106. PubMed ID: 7508723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HIV-1 and HIV-2 activity of naphthalenedisulfonic acid derivatives. Inhibition of cytopathogenesis, giant cell formation, and reverse transcriptase activity.
    Mohan P; Singh R; Baba M
    Biochem Pharmacol; 1991 Feb; 41(4):642-6. PubMed ID: 1705124
    [No Abstract]   [Full Text] [Related]  

  • 12. New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase.
    Bellarosa D; Antonelli G; Bambacioni F; Giannotti D; Viti G; Nannicini R; Giachetti A; Dianzani F; Witvrouw M; Pauwels R; Desmyter J; De Clercq E
    Antiviral Res; 1996 May; 30(2-3):109-24. PubMed ID: 8783803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics.
    Balzarini J; Pannecouque C; De Clercq E; Pavlov AY; Printsevskaya SS; Miroshnikova OV; Reznikova MI; Preobrazhenskaya MN
    J Med Chem; 2003 Jun; 46(13):2755-64. PubMed ID: 12801238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lignified materials as medicinal resources. V. Anti-HIV (human immunodeficiency virus) activity of some synthetic lignins.
    Nakashima H; Murakami T; Yamamoto N; Naoe T; Kawazoe Y; Konno K; Sakagami H
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2102-5. PubMed ID: 1423763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-HIV activity of 10,11-dihydropyrrolo [1,2-b][1,2,5]benzothiadiazepine-11-acetic acid 5,5-dioxide derivatives and related compounds.
    Silvestri R; Artico M; Pagnozzi E; Stefancich G; Massa S; La Colla P; Loi AG; Spiga MG; Corrias S; Lichino D
    Farmaco; 1996 Jun; 51(6):425-30. PubMed ID: 8766226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral oligo- and polyribonucleotides containing selected triazolo[2,3-a]purines.
    Tutonda MG; Buckheit RW; Agrawal VK; Broom AD
    J Med Chem; 1998 Dec; 41(25):4958-64. PubMed ID: 9836613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.
    Pauwels R; Andries K; Desmyter J; Schols D; Kukla MJ; Breslin HJ; Raeymaeckers A; Van Gelder J; Woestenborghs R; Heykants J
    Nature; 1990 Feb; 343(6257):470-4. PubMed ID: 1689015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential cytopathicity and susceptibility of Ghanaian highly divergent HIV-2 -GH2-, prototype HIV-2 -GH1-, and prototype HIV-1 -GH3- to inhibition by ddCyd and ddIno.
    Ayisi NK
    East Afr Med J; 1995 Oct; 72(10):654-7. PubMed ID: 8904046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.